HRES 449 · 104th Congress · Health

Relating to breast implants, the Food and Drug Administration, and breast care.

Introduced 1996-06-06· Sponsored by Rep. Vucanovich, Barbara F. [R-NV-2]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health and Environment.(1996-06-14)

Plain Language Summary

[AI summary unavailable — showing source text] Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

8 Democrats12 Republicans